Teradyne Third Quarter 2026 Earnings - TERADYNE INC

Explicit Guidance:

• Q4 2026 Revenue: Expected range of $1.25 billion to $1.35 billion, representing ~20% YoY growth.
• Q4 2026 Non-GAAP EPS: Expected range of $1.95 to $2.25.
• Q4 2026 Gross Margin: Expected range of 57.5% to 58.5%, driven by product mix and new launches.
• Q4 2026 Operating Expenses: Expected to run at 28.5% to 29.5% of sales, reflecting continued R&D and go-to-market investment.
• Q4 2026 Non-GAAP Operating Profit Rate: Expected between 28% and 30%.
• Full Year 2026 Revenue: Projected to reach approximately $5.2 billion (up >60% YoY) based on the Q4 guidance midpoint.
• FY 2027 Outlook: Management expects "healthy growth" for the full year 2027, driven by a strengthening backlog and compute momentum; specific quantitative guidance for FY 2027 (revenue, margins) will be updated on the Q4 earnings call.
• Q1 2027 Directional: Expects revenue growth QoQ from Q4 2026 to Q1 2027, with quarters in 2027 expected to grow sequentially vs. 2026, though variability within quarters is possible.

Business-Segment Outlook:

• Semiconductor Test (Semitest):
  • Compute (SOC): Expects healthy growth in 2027 driven by dual vendor strategies; compute order timing was at a low in Q3 2026 and expected to re-accelerate in Q4.
  • Dual Vendor Progression: First hyperscaler customer in "mature" phase; second hyperscaler customer in "fast follower" phase with capacity buys expected in the second half of 2027; third hyperscaler in "initial qualification." Next major ramp for the first customer expected mid-2027.
  • Memory: Expecting significant YoY growth in 2027 due to fab expansions coming online. HBM identified as the primary growth driver for the segment in 2027, with expected growth across DDR, LPDDR, and NAND. HBM test TAM expected to increase as AI accelerators utilize lower stack heights to maximize wafer yield, potentially increasing Teradyne's share.
  • Auto & Industrial: Revenue grew <90% YoY in Q3; trend expected to accelerate with 800-volt standards and IVR technologies.
  • Memory & Networking: Networking device test demand (switches, retimers, DSPs) expected to grow strongly alongside compute.
• Product Test Group: Revenue expected to continue broad-based growth in Q4 and 2027 tied to AI infrastructure. Multi-lane test products (MLTP JV) anticipated to see strength as data center interconnect needs rise.
• Robotics:
  • Physical AI: Currently in early innings; "gestation period" expected for lab solutions before end-market growth.
  • Growth Timeline: Robust growth in transactions with labs expected in 2027; significant end-market (field) growth in robotics expected to materialize primarily in 2028.
  • Customers: Large customer (distribution centers) transitioning from engineering proof to broad deployment in 2027, leading to potential back-half loading for that segment.
• R&D & Product Roadmap:
  • New Instruments: Ultraflex Plus instruments (Ultrapin 5000 EM, UltraVS64HP, UltraPort PCIe 6) introduced for 2027 device testing. IRIS 100 for optical test launched in Q3.
  • Capacity: Ultraflex Plus capacity currently at 4x levels of 18 months ago; planning next capacity step-up. Dual vendor qualification for memory and Eagle power test lines in progress.

Market and Competitive Outlook:

• ATE TAM: Forecasts for 2027, 2028, and beyond are being revised upward; conditions deemed right for prolonged ATE TAM expansion.
• Share Gains: Competitor share gains are being diluted by the sheer size of the expanding compute market; Teradyne expects modest share gains in compute and strong gains in memory/performance test.
• CPO/MPO: CPO TAM estimated at ~$100M in 2026, growing to $300M–$700M by 2028, potentially reaching $1B+. Initial ramp expected in 2027 from a small base; timing dependent on economics and assembly flow refinement.
• Supply Chain: Lead times for components have lengthened; Teradyne is holding lead times but customers are providing better forecasting visibility.
• Pricing/Mix: Q4 gross margin guidance reflects negative product mix impact from new launches, though volume is strong. 2027 gross margins expected to face equal "headwinds" (inflation, capacity investment costs) and "tailwinds" (volume, mix, cost efficiency).

Macro / Industry Outlook:

• AI Waves: Current period (2026) is the "second wave" of AI (optimized data centers for agentic AI). Third wave (physical/edge AI in automotive, robotics, wearables) is in early stages with full impact pending.
• Semiconductor Capex: Semi-capex associated with test rising from 6.4% (2025) to 8.1% (YTD 2026).
• Inventory Dynamics: Inventory increased ~$200M over six months due to preparation for 2027 growth and longer component lead times; expected to normalize to ~200 DIO (from Q1 2026 lows).
• HDD/Storage: Annual exabyte growth for HDD exceeding 20% in 2026 due to AI data center needs.
• Market Shift: Historical mobile-driven cycles (pre-2024) deemed obsolete; current market dynamics driven by data center build schedules and semiconductor capacity constraints.

Strategic Initiatives:

• M&A: "Form factor" investment expected to close in Q4 2026 (subject to regulatory approval); remaining portfolio in full effect in H2 2027.
• Partnerships: New partnership with FormFactor for optical tests; existing partnerships with Technoprobe and Ficontech maintained. Robot ecosystem partnerships with NVIDIA, Analog Devices, Scale AI, Bright Machines, and C-React.
• Capacity Expansion: Aggressive capacity additions for memory test, Eagle power test, and Ultraflex Plus platforms.
• Capital Allocation: 2026 investment of ~$1 billion in R&D and CapEx (R&D >10% of sales). Strategy to maintain cash reserves, return capital via dividends ($20M in Q3) and buybacks ($99M in Q3), and maintain dry powder for M&A.

Risks and Headwinds to Outlook:

• Gross Margin Pressures: Inflationary pressures across the supply ecosystem and increased capacity investment costs in 2027 may pressure margins despite volume growth.
• Product Mix: Sequential margin declines in Q4 expected due to mix shifts from new product launches.
• Timing/Lumpiness: Quarter-to-quarter variability remains possible due to test cell construction timing and shipment lumps; specific Q1 guidance not provided to account for this.
• Regulatory: Form factor deal closure subject to regulatory approval.
• Market Uncertainty: CPO and edge AI adoption timelines depend on refinement of assembly flows and economic viability.
• Supply Constraints: Longer lead times for components could delay responsiveness to spot demand if not forecasted correctly.

Management Tone on the Future:

• Confidence: High confidence in mid-term growth plans; describes the current state as a "rising tide" driven by AI.
• Optimism: Optimistic about 2027 and 2028, noting the ability to look out to 2028 with conversations about long-term targets, a shift from previous quarters.
• Strategy Validation: Belief that "wafer-to-data center" strategy is delivering results, with AI revenue comprising >60% of total.
• Caution: Avoids specific 2027 quantitative modeling until Q4 call; emphasizes that historical patterns (pre-2024) are no longer applicable to the current market structure.

Miscellaneous:

• Silent Period: Quiet period begins Dec 18, 2026.
• Investor Relations: Teradyne to participate in a UBS technology-focused investor conference; updated earnings model to be discussed in Q4 2026 call.
• Financial Position: Ended Q3 2026 with $625M cash/investments; FCF for 9 months 2026 was $806M.